1.72
0.00
(-0.29%)
May 17 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | 1.72 - 1.72 |
| 52 week | 1.40 - 2.10 |
| Open | 1.72 |
| Vol / Avg. | 25,000.00/645.00 |
| Mkt cap | 11.00M* |
| P/E | 18.11 |
| Div/yield | - |
| EPS | 0.00* |
| Shares | 639.36M |
| Beta | - |
| Inst. own | - |
| *GBP |
Events
Mar 18, 2013
Interim 2012 Antisoma plc Earnings Release
|
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -44.12% | 57.03% |
| Operating margin | -123.53% | 87.14% |
| EBITD margin | - | 57.64% |
| Return on average assets | -0.41% | 2.58% |
| Return on average equity | -0.46% | 3.57% |
| Employees | 43 | - |
| Carbon Disclosure Rating | - | - |
Address
Mitre House 160 Aldersgate Street
LONDON, ENG EC1A 4DD
United Kingdom - Map
+44-20-70997268 (Phone)
+44-20-87998201 (Fax)
LONDON, ENG EC1A 4DD
United Kingdom - Map
+44-20-70997268 (Phone)
+44-20-87998201 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
Antisoma plc (Antisoma) is as an investing company. The principal activity of the Company is the investment in and growth and development of businesses. Antisoma's segment includes Portfolio Investment return. All Portfolio investment return is derived from the United Kingdom and other income from the United States. Antisoma's equity interest in an investment may range from a minority position to 100% ownership and the interest may be either quoted or unquoted.
Officers and directors
| Christopher Hill | Company Secretary | |
| Michael Anthony Bretherton | Non-Executive Director | |
| Michael Lewis | Non-Executive Independent Director |